| Ticker Details |
|
Embecta Corp.
|
| IPO Date: |
April 1, 2022 |
| Sector: |
Healthcare |
| Industry: |
Drug Manufacturers - Specialty and Generic |
| Market Cap: |
$635.43M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.42 | 2.17%
|
| Avg Daily Range (30 D): |
$0.27 | 2.38%
|
| Avg Daily Range (90 D): |
$0.26 | 2.08%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.47M |
| Avg Daily Volume (30 D): |
.6M |
| Avg Daily Volume (90 D): |
.46M |
| Trade Size |
| Avg Trade Size (Sh.): |
60 |
| Avg Trade Size (Sh.) (30 D): |
57 |
| Avg Trade Size (Sh.) (90 D): |
52 |
| Institutional Trades |
| Total Institutional Trades: |
1,491 |
| Avg Institutional Trade: |
$2.21M |
| Avg Institutional Trade (30 D): |
$1.81M |
| Avg Institutional Trade (90 D): |
$1.7M |
| Avg Institutional Trade Volume: |
.11M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.41M |
| Avg Closing Trade (30 D): |
$1.86M |
| Avg Closing Trade (90 D): |
$1.74M |
| Avg Closing Volume: |
119.05K |
|
|
| Financials |
| |
TTM |
Q1 2026 |
Q4 2025 |
|
Basic EPS
|
$2.39
|
$.75
|
$.46
|
|
Diluted EPS
|
$2.36
|
$.74
|
$.44
|
|
Revenue
|
$1.08B
|
$261.2M
|
$264M
|
|
Gross Profit
|
$681.4M
|
$161.7M
|
$158.5M
|
|
Net Income / Loss
|
$139.5M
|
$44.1M
|
$26.4M
|
|
Operating Income / Loss
|
$296.7M
|
$83.3M
|
$56.5M
|
|
Cost of Revenue
|
$398.3M
|
$99.5M
|
$105.5M
|
|
Net Cash Flow
|
$-17.2M
|
$-24.9M
|
$-4.9M
|
|
PE Ratio
|
4.36
|
|
|
|
|
|